As of 2025-10-27, the EV/EBITDA ratio of Vanda Pharmaceuticals Inc (VNDA) is -4.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VNDA's latest enterprise value is 325.00 mil USD. VNDA's TTM EBITDA according to its financial statements is -70.05 mil USD. Dividing these 2 quantities gives us the above VNDA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 13.5x | 12.6x |
| Forward P/E multiples | 15.3x - 26.1x | 17.7x |
| Fair Price | (18.09) - (15.96) | (17.99) |
| Upside | -428.9% - -390.1% | -427.1% |
| Date | EV/EBITDA |